A 4550New Jersey
Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.
In committee
Mar 10, 2026: Introduced, Referred to Assembly Financial Institutions and Insurance Committee